Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO TAT 2022 | Total-body PET: Applications and unmet needs

David Mankoff • 30 Mar 2022
ESMO TAT 2022
General

David Mankoff, MD, PhD, University of Pennsylvania, Philadelphia, PA, explains total-body PET, the variety of devices currently in use, and the possible applications to clinical practice and research, as well as the key challenges that still need to be overcome. This interview was conducted at the virtual European Society for Medical Oncology Targeted Anti-Cancer Therapies (ESMO TAT) Congress 2022.

More from David Mankoff

3:04
Using imaging of steroid receptor and PARP targets to improve endocrine therapy
David Mankoff • 30 Mar 2022
3:52
Potential of molecular imaging be used as a biomarker in cancer care
David Mankoff • 30 Mar 2022
2:18
Importance of collaboration between imaging specialists and oncologists
David Mankoff • 30 Mar 2022

Related Videos

1:56
Phase I trial of trastuzumab deruxtecan and neratinib in HER2-altered tumors
Haeseong Park • 8 Apr 2024
2:45
Remaining challenges in treating solid tumors with CAR-Treg therapy
Leonardo Ferreira • 8 Apr 2024
2:01
Engineering chimeric antigen receptor regulatory T cells for treating cancer
Leonardo Ferreira • 8 Apr 2024
0:59
What challenges are there in using CAR-T cells for solid tumors?
Leonardo Ferreira • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals